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• PLAG1 enhances the stemness profile in acinar cells in normal human salivary glands. 
• PLAG1 enhances the stemness profile in a cell-type-specific manner. 
• PLAG1 up-regulates the expression of genes involved in the stemness-related pathway. 
• PLAG1 may cause tumorigenesis by increasing the stemness character of the cells.  
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Objectives: Details of the histogenesis of salivary gland tumors are largely unknown. The 
oncogenic role of PLAG1 in the salivary gland has been demonstrated in vivo. Herein, we 
demonstrate the roles of PLAG1 in the acinar and ductal cells of normal human salivary glands in 
an attempt to clarify the early events that occur during the histogenesis of salivary gland tumors.  
Methods: Normal salivary gland cells with acinar- (NS-SV-AC) and ductal- (NS-SV-DC) 
phenotypes were transfected with PLAG1 plasmid DNA. Subsequently, the PLAG1 overexpressed 
and mock cells were examined by cell proliferation, transwell migration, and salisphere formation 
assays. The expression levels of salivary and pluripotent stem cell markers and differentiation 
markers were evaluated by quantitative real-time polymerase chain reaction and 
immunofluorescence. Alterations in transcriptional expressions were investigated via cap analysis 
of gene expression with gene-enrichment and functional annotation analysis. 
Results: PLAG1 promoted cell proliferation and transwell migration in the acinar and ductal cells, 
and markedly enhanced the stemness profiles and luminal cell-like profiles in acinar cells; the 
stemness profiles were partially increased in the ductal cells.  
Conclusion: PLAG1 enhanced the stemness profiles in the acinar cells of normal human salivary 
glands in a cell type-specific manner. Thus, it may be involved in salivary gland tumorigenesis by 
increasing the stemness character of the normal salivary gland cells. 
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1. Introduction  
Pleomorphic adenoma gene 1 (PLAG1) is a crucial oncogene involved in the development 
of pleomorphic adenomas in the salivary glands [1]. Tumorigenesis is caused by the swapping of 
promoters between PLAG1 and beta-catenin through chromosomal reciprocal translocations [2]. 
These events cause the ectopic overexpression of PLAG1, which is driven by the constitutively 
active beta-catenin promoter. The definite oncogenic capacity of PLAG1 has been demonstrated in 
vivo; moreover, PLAG1 overexpression in the salivary gland caused the development of a tumor in 
the salivary gland [3]. Human insulin-like growth factor 2 (IGF2) gene is the representative target 
gene of PLAG1 with regard to tumorigenesis [1]. PLAG1 binds to IGF2 promoter 3 and stimulates 
its activity; IGF2 transcripts derived from the P3 promoter are highly expressed in salivary gland 
pleomorphic adenomas that overexpress PLAG1 [4]. PLAG1 influences tumorigenesis, at least in 
part, via the mitogenic action of IGF2, presumably by the activation of IGF1R and the 
Ras/Raf/MAPK signaling pathway in NIH3T3 cells [5, 6].  
 The histogenesis of salivary gland tumors is not well understood because they are generally 
well-developed during surgical resection. Among the few hypothetical concepts of the histogenesis 
of salivary gland tumors, the most novel one is a multicellular theory that involves the 
differentiation of cells at all the levels of the gland; the acinar and basal cells were also thought to 
be capable of cell division, and were presented as the hypothetical cells of origin for salivary gland 
neoplasms [7]. This concept is based on the findings of an autoradiography study in adult female 
mouse submandibular glands, wherein basal, luminal, and acinar cells were found to be capable of 
DNA synthesis and mitosis [8]. These results overlap with recent evidence that suggests that 
differentiated acinar cells are self-duplicating and maintained without significant input from 
stem/progenitor cells in the intercalated duct in adult salivary glands [9, 10]. Furthermore, it has 
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been shown that there are more than one progenitor cell population in the adult salivary gland [11]. 
However, whether the stem/progenitor cells in normal salivary glands are directly transformed into 
cancer stem cells is poorly understood; moreover, the origin of cancer stem cells in normal salivary 
glands remains unknown [12, 13].  
 In this study, we report the roles of PLAG1 in acinar and ductal cells of normal human 
salivary glands in order to elucidate the early events of the histogenesis of salivary gland tumors.  
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2. Materials and methods 
2.1. Plasmid construction for human PLAG1 overexpression 
Full-length, human PLAG1 cDNAs subcloned into pCR4-TOPO were purchased from 
DNAFORM (Yokohama, Kanagawa, Japan). The adaptors of EcoRI and BglII sites were added to 
the 5’ and 3’ side ends of the full-length cDNAs by PCR amplification using the following primer 
sets: 5'-GAATTCCGCCACTGTCATTCCTGGT-3' (for the addition of the EcoRI site to the 5’ side 
end) and 5'-AGATCTCTACTGAAAAGCTTGATGGAA-3' (for the addition of the BglII site to the 
3’ side end). The PCR product was subcloned by insertion into a TOPO TA vector (ThermoFisher 
Scientific, CA, USA). The EcoRI- BglII fragment, including the PLAG1 cDNA from the TOPO TA 
vector, was inserted into the multi-cloning site of the p3XFLAG-Myc-CMV-26 expression vector 
(Sigma-Aldrich Co, CA, USA). All gene recombination experiments were approved by the Gene 
Recombination Experiment Safety Committee of Iwate Medical University (Permit Number: 528). 
 
2.2. Cell culture 
 Immortalized normal human salivary gland acinar (NS-SV-AC) and ductal (NS-SV-DC) 
cell lines were used in this study. Detailed characteristics of these cells have been described 
elsewhere [14]. The cells were maintained in Keratinocyte-serum-free medium supplemented with 
50 μg/ml bovine pituitary extract, 5 ng/ml human recombinant epithelial growth factor (EGF; Gibco, 
Life Technologies, NY, USA), and antibiotics (Nacalai Tesque, Kyoto, Japan) at 37°C in a 
humidified atmosphere containing 5% CO2. For plasmid DNA transfection, the cells were grown to 
70%–80% confluency and transfected with the human PLAG1 construct or an empty vector 
(negative control) using FUGENETM HD transfection reagent (Promega Corporation, Madison, WI, 
USA). At 24 h after transfection, we observed and photographed the cell morphology using the 
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Keyence microscope BZ-X710 (Keyence, Tokyo, Japan). After confirming the overexpression of 
PLAG1 in the cells by immunoblotting, the transfected cells were used for subsequent analysis. 
 
2.3. Western blot analysis 
The cells were washed with cold phosphate-buffered saline (Takara, Shiga, Japan) and lysed 
in RIPA buffer (Nacarai Tesque, Kyoto, Japan). After centrifugation, the supernatant was collected 
and protein concentrations were determined by microplate assay (DC Protein Assay Kit, Bio-Rad 
Laboratories, Hercules, CA, USA) according to the manufacturer's instructions. Five micrograms of 
protein were loaded and resolved in SDS-polyacrylamide gel and transferred to a PVDF membrane 
using the Trans-Blot Turbo Transfer System (Bio-Rad Laboratories, Hercules, CA, USA). The 
membrane was blocked in 2.5% ECL Blocking Agent (GE Healthcare, Fairfield, CT, USA) for 30 
min, and then probed with mouse monoclonal anti-human PLAG1 primary antibody (clone; 3B7, 
H00005324-M02, Abnova, Taipei, Taiwan) and mouse monoclonal anti- glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) primary antibody (clone; 0411, sc-47724, Santa Cruz Biotechnology, CA, 
USA) at room temperature for 1 h. After washing in Tris-buffered saline (Takara, Kyoto, Japan) 
containing 0.1% tween 20 (Sigma-Aldrich, St. Louis, MO, USA), the membranes were incubated 
with horseradish peroxidase-conjugated secondary antibody (NA931V, GE Healthcare, 
Buckinghamshire, UK) at room temperature for 1 h. The antibody used for GAPDH detection was 
diluted with Can Get Signal solution (TOYOBO CO., LTD., Osaka, Japan). The blots were visualized 
with ECL or ECL select Western Blotting Detection Reagent (GE Healthcare, Buckinghamshire, UK) 
followed by scanning with the ChemiDoc XRS Plus System and analysis with Image Lab Software 
(Bio-Rad Laboratories, Hercules, CA, USA). 
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2.4. Cell proliferation assay 
Human PLAG1 or empty vector-transfected cells were plated into a 96-well plate (1.0 × 104 
cells per well), and after 5 days of culture, assessed by addition of 10 μl of WST-8 solution (Cell 
Count Reagent SF; Nacalai Tesque, Kyoto, Japan) followed by further incubation for 2 h. The 
absorbance was measured at a wavelength of 450 nm using the CHROMATE 4300 microplate reader 
(Awareness Technology Inc., FL, USA); the absorption at 630 nm was used as a reference. All 
experiments were performed in quadruplicate (acinar cells) or septuplicate (ductal cells). 
 
2.5. Matrigel transwell migration assay  
The Matrigel transwell migration assay was performed using FalconR cell culture inserts (8 
μm pore size; Coring, NY, USA). The inserts were coated with BD Matrigel Basement Membrane 
Matrix (Coring, NY, USA) following which, the transfected cells (5 × 104) were inoculated into the 
upper chamber of the cell culture insert. The growth medium was placed in the lower well of the 
24-well companion plate and the cells were incubated for 24 h at 37°C in 5% CO2. After 24 h, the 
cells on the upper surface of the membrane were removed with a cotton swab, and the membrane was 
fixed with 100% methanol followed by staining with hematoxylin (Muto Pure Chemicals, Tokyo, 
Japan). The cells that had migrated into the lower side of the membrane were observed under a 
microscope (OLYMPUS AX80, Tokyo, Japan) equipped with a CCD digital camera (OLYMPUS 
DP70, Tokyo, Japan) and counted.  
 
2.6. Salisphere culture 
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The transfected cells were suspended in DMEM/F12 (Gibco, Life Technologies, NY, USA)
containing antibiotic, N2 supplement (Gibco, Life Technologies, NY, USA), human recombinant 
fibroblast growth factor 2 (FGF2 20 ng/ml; Sigma-Aldrich, St. Louis, MO, USA), EGF (20 ng/ml; 
Sigma-Aldrich, St. Louis, MO, USA), insulin (10 μg/ml; Sigma-Aldrich, St. Louis, MO, USA), and 
dexamethasone (1 μM; Sigma-Aldrich, St. Louis, MO, USA), and mixed with Corning Matrigel 
Basement Membrane Matrix (Corning, NY, USA) to 2:1 ratio. The cells were plated in a 24-well plate 
at a density of 1 × 104 cells per well and cultured for 12 to 14 days at 37°C in 5% CO2. The medium 
was changed every three days. For salisphere collection, they were released from the Matrigel by Cell 
Recovery Solution (Corning, NY, USA) according to the manufactures’ protocol. 
 
2.7. Immunohistochemistry 
The salispheres were embedded in ipGell (PG20-1, Genostaff, Tokyo, Japan) and fixed with 
4% paraformaldehyde (PFA; Nacalai Tesque, Kyoto, Japan). After sucrose replacement, the fixed 
salispheres were embedded in Tissue-Tek O.C.T. compound (Sakura Finetechnical Co. Ltd., Tokyo, 
Japan) and sectioned (thickness, 6 m). The sections were stained with hematoxylin and eosin (HE), 
or incubated with primary Aquaporin 5 (AQP5: PA5-36529, Invitrogen, Waltham, USA), cytokeratin 
18 (CK18: 10830-1-AP, Protein Tech, IL, USA), cytokeratin 14 (CK14: clone:LL002, MCA890H, 
AbD Serotec Ltd., Oxford, UK), alpha-smooth muscle actin (αSMA: clone:GT445, GTX629702, 
GeneTex International Corporation, Hsinchu, Taiwan), POU5F1 (also known as Oct4, 
clone:EPR17929, ab181557, Abcam Cambridge, UK), NANOG (clone: EPR2027(2), ab109250, 
Abcam Cambridge, UK), leucine-rich repeat-containing G-protein-coupled protein 5 (LGR5, also 
known as GPR49, clone:OTI2A2, MA5-25644, Invitrogen, Waltham, USA) and THY1 (also known 
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as CD90: clone:EPR3133, ab133350, Abcam Cambridge, UK) antibodies. For the 
immunofluorescent staining, the sections were incubated with Alexa Flour anti-mouse IgG 568 
(ab175472, Abcam Cambridge, UK) or anti-Rabbit IgG 594 (A11037, Invitrogen, Waltham, USA) 
and stained with 4’-6diamidino-2-phenylindole (DAPI: D9542, Sigma-Aldrich Japan, Tokyo, Japan). 
The stained images were observed and obtained using the Keyence microscope BZ-X710. 
  
2.8. Real-time quantitative PCR (qRT-PCR) 
 Total RNA was extracted using the RNeasy Plus Mini kit (QIAGEN, Tokyo, Japan) and 
reverse transcribed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster, CA, USA) according to the manufacturer’s instruction. Quantitative real-time polymerase 
chain reaction (qRT-PCR) was carried out in triplicate using a 7500 Real-Time PCR system (Applied 
Biosystems, Foster, CA, USA). Nine μl of the diluted cDNA, 1 μl of PCR primer set, and 10 μl of 
Power SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK) were used according to 
the manufacturer's instructions. The primers used for amplification were as follows: AQP5, forward: 
5’-ACTGGGTTTTCTGGGTAGGG-3’ and reverse: 5’-GTGGTCAGCTCCATGGTCTT -3’; CK18, 
forward: 5’-TGGTCACCACACAGTCTGCT -3’ and reverse: 5’-CCAAGGCATCACCAAGATTA 
-3’; CK14, forward: 5’-TGAGCCGCATTCTGAACGAG-3’ and reverse: 
5’-GATGACTGCGATCCAGAGGA-3’; -SMA, forward: 5’-CGATAGAACACGGCATCATC-3’ 
and reverse: 5’-CATCAGGCAGTTCGTAGCTC -3’; POU5F1, forward: 
5’-AAGCGATCAAGCAGCGACTA-3’ and reverse: 5’-GAAGTGAGGGCTCCCATAGC-3’; 
NANOG, forward: 5’-CAGAAAAACAACTGGCCGAA -3’ and reverse: 
5’-GGCCTGATTGTTCCAGGATT-3’; LGR5, forward: 5’-AGGATCTGGTGAGCCTGAGAA-3’ 
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and reverse: 5’-CATAAGTGATGCTGGAGCTGGTAA-3’; THY1, forward: 
5’-GACAGCCTGAGAGGGTCTTG-3’ and reverse: 5’-CCCAGTGAAGATGCAGGTTT-3’; 
GAPDH, forward: 5’-ATGGGGAAGGTGAAGGTCG-3’ and reverse: 
5’-TAAAAGCAAGCCCTGGTGACC-3’. The PCR conditions consisted of enzyme activation for 2 
min at 50°C and 10 min at 95°C, followed by 35 cycles of denaturation at 95°C for 15 s and 
annealing/extension at 60°C for 1 min. Cycle threshold (Ct) data were collected using the Sequence 
Detection Systems 1.4 software (Applied Biosystems, Foster, CA, USA). Quantitative amplification 
of GAPDH cDNA was performed and used as normalization control. The relative gene expression 
was calculated by transforming the difference in Ct values between the control and the target using 
the following equation: relative gene expression = 2− (Ct target−Ct control). 
   
2.9. Cap analysis of gene expression (CAGE). 
Cap analysis of gene expression (CAGE) library preparation, sequencing, mapping, and 
gene expression analysis were performed by DNAFORM (Yokohama, Kanagawa, Japan). In brief, 
RNA quality was assessed with a Bioanalyzer (Agilent) to ensure that the RIN (RNA integrity 
number) was above 7.0 and the A260/280 and 260/230 ratios are above 1.7. First-strand cDNAs 
were transcribed to the 5’ ends of capped RNAs and attached to CAGE "bar code" tags; the 
sequenced CAGE tags were mapped to the mouse mm9 genomes using the BWA software (v0.5.9) 
after discarding ribosomal or non-A/C/G/T base-containing RNAs. The CAGE-tag 5’ coordinates 
were input for CAGEr clustering [15] using the Paraclu algorithm [16] with default parameters. The 
up-regulated genes in PLAG1 were overexpressed in the acinar and ductal cells when compared 
with the mock cells and identified with a threshold log2 fold change of >2.0, whereas the 
Journal of Oral Biosciences 
Y. Goto et al. 
12 
 
down-regulated genes in the cells were identified with a threshold log2 fold change of < -2.0. 
 
2.10. Gene-enrichment and functional annotation analysis of CAGE data 
To explore the function of PLAG1 in normal human salivary gland acinar and ductal cells, 
a gene ontology (GO) term enrichment analysis was performed using the DAVID database 
(https://david.ncifcrf.gov/). The GO term enrichment analysis was carried out using the annotation 
category of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Differences with P 
< 0.05 were regarded as statistically significant. 
 
2.11. Statistical analysis 
Data were analyzed and presented using GraphPad QuickCals 
(https://www.graphpad.com/quickcalcs/, GraphPad Software, San Diego, CA, USA). The two-tailed 
Student's t-test was used to analyze the differences between two groups. Data are presented as mean  
standard deviation (SD) with P < 0.05 considered as statistically significant.
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3. Results  
3.1. PLAG1 does not cause remarkable changes in the morphological features of acinar and ductal 
cells  
To examine the function of PLAG1 in salivary gland cells, the human PLAG1 DNA 
plasmid was transfected with NS-SV-AC (acinar cells) and NS-SV-DC (ductal cells) [14]. After 24 
h, no significant changes in the morphologies of both acinar and ductal cells were observed (Fig. 
1A). The overexpression of PLAG1 in both cells at 24 and 48 h after PLAG1 transfection was 
confirmed by immunoblotting (Fig. 1B). Based on these results, the following experiments were 
performed using the cells that were transfected with PLAG1 for 24 h. 
 
3.2. PLAG1 promotes cell proliferation and transwell migration of acinar and ductal cells 
 Cell proliferation assays revealed that PLAG1 significantly increased the proliferative 
capacity of both acinar and ductal cells after five days of culture (Fig. 2A). PLAG1 also increased 
transwell migration of both acinar and ductal cells (Figs. 2B, C).  
 
3.3. PLAG1 enhances luminal cell-like profiles in acinar cells, but not in ductal cells 
To investigate how PLAG1 influences the differentiation of acinar and ductal cells in a 
biological environment that partially mimics the very early stage of salivary gland tumor, we 
utilized a salisphere culture that has been used to grow adult salivary gland epithelial cells into 3D 
clusters for in vitro differentiation studies [17]. In salispheres composed of acinar cells, PLAG1 
induced the mRNA expression of AQP5, an acinar cell marker, and CK18, a ductal cell marker, but 
not CK14, a basal cell marker, and α-SMA, a myoepithelial cell marker (Fig. 3B). These results 
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were compatible with those of immunofluorescence (Fig. 3C) indicating that PLAG1 enhances the 
luminal cell-like profiles in the salispheres of acinar cells. In the ductal cells, no remarkable 
changes in the differentiation of the ductal cell characters were noted, but a slight reduction in the 
basal cell-like character of the ductal cells was observed (Fig. 4B). Furthermore, PLAG1 attenuated 
the mRNA expression levels of CK14, but not AQP5, CK18, and α-SMA; these results were 
compatible with those of immunofluorescence (Fig. 4C). Interestingly, PLAG1 influenced the 
differentiation of acinar and ductal cells in a cell type-specific manner. 
 
3.4. PLAG1 enhances the stemness profile in acinar cells  
Next, we examined whether PLAG1 affects the expression of stemness markers in acinar 
and ductal cells. Several stem/progenitor cell markers have been reported in human salivary gland 
cells [18-20]. We analyzed the expression of pluripotent cell markers, POU5F1 (Oct4) and NANOG, 
and salivary gland stem cell markers, leucine-rich repeat-containing G-protein-coupled protein 5 
(LGR5) and THY1 (CD90) by qRT-PCR and immunohistochemistry in the salispheres of the acinar 
and ductal cells. Interestingly, the mRNA and protein expression levels of NANOG, LGR5, and 
THY1 were markedly up-regulated in the acinar cells (Fig. 5), whereas in the ductal cells, only 
THY1 was significantly up-regulated (Fig. 6).  
 
3.5. Pathways concerning stemness and cancer were enriched among differentially up-regulated 
genes in acinar cells with PLAG1 overexpression.  
CAGE analysis revealed 849 up-regulated and 120 down-regulated genes in the acinar cells 
and 445 up-regulated and 80 down-regulated genes in the ductal cells that overexpressed PLAG1. 
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The functions of these genes in the cells were investigated by subjecting them to a GO term 
enrichment analysis (Table 1, 2). The results of the analysis indicated that the up-regulated genes in 
the acinar cells with PLAG1 overexpression predominantly participated in cancer-related pathways, 
including “Pathways in cancer”, “Ras signaling pathway”, “Basal cell carcinoma”, “PI3K-Akt 
signaling pathway” and “MAPK signaling pathway” and in stemness-related pathways, such as the 
“Signaling pathways regulating pluripotency of stem cells” (Table 1). Likewise, the up-regulated 
genes in the ductal cells with PLAG1 overexpression appeared to predominantly participate in the 
cancer-related pathways (out of the top 10), but not in the stemness-related pathway (Table 2). 
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 In the present study, we showed that PLAG1 enhanced the stemness profiles predominantly 
in acinar cells, but only to some extent in ductal cells in normal human salivary glands. PLAG1 
enhanced the luminal cell-like characters of acinar cells but caused unremarkable changes in the 
ductal cells. PLAG1 influenced the stemness profiles and differentiation in a cell type-specific 
manner in the normal human salivary gland cells.  
Little is known about the involvement of PLAG1 in stemness. It has been reported that 
PLAG1 and upstream stimulating factor-2 (USF2) co-regulate the expression of Musashi-2 and play 
a key role in the function of hematopoietic stem and progenitor cells [21]. PLAG family genes are 
expressed in the progenitor cells of the cerebellar lineage in the developing cerebellum during the 
early stages of the mouse embryo [22]. These facts suggest that PLAG1 plays a potential role in 
stemness in the hematopoietic and neuronal systems; however, the physiological role of PLAG1 
with regard to stemness in normal human salivary gland cells remains unknown. The results of the 
present study demonstrated that the overexpression of PLAG1 in normal salivary gland acinar cells 
resulted in the transcriptional activation of pluripotent stem cells and salivary stem/progenitor cell 
markers. To date, the exact mechanism by which PLAG1 exerts the induction of stemness in normal 
human salivary gland cells remains unclear. Wingless/integrated (Wnt) is a key molecule in most 
types of stem cells in adult mammals [23]. Earlier studies demonstrated that the Wnt signaling 
pathway was activated through the upregulation of β-catenin in salivary gland tumors induced by 
the overexpression of PLAG1 in transgenic mice [24]. In addition, the three-dimensional spheroid 
culture of human salivary gland-resident stem cells in nanofibrous microwells has been shown to 
promote stem cell properties via Wnt signaling activation [20]. Therefore, it is suggested that the 
Wnt/β-catenin signaling pathway could play an important role in the enhancement of the stemness 
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profile by PLAG1 overexpression in normal human salivary gland cells. This is in accordance with 
the results of the GO term enrichment analysis in this study wherein, the up-regulated genes in the 
acinar cells that overexpressed PLAG1 (including WNT1, 3A, 5A, 7A, 7B, and 11) were found to 
be predominantly involved in the stemness-related pathway (Table 1). Moreover, the Rap1 signaling 
pathway was found to be involved in the acinar cells with PLAG1 overexpression. Recently, it was 
reported that the Rap1 activation status in hematopoietic stem/progenitor cells (HSPC) is important 
for maintaining HSPC at the bone marrow niche for long-term hematopoiesis in adults [25]. Thus, 
PLAG1 appeared to enhance the stemness profiles in the acinar cells via Wnt and other signaling 
pathways (such as the Rap1 signaling pathway). However, the mechanism by which PLAG1 
enhances the stemness in salivary gland cells needs to be evaluated in the future. 
Our results demonstrated that PLAG1 enhances luminal cell-like profiles in the acinar cells 
using the salisphere culture, which suggested that PLAG1 promotes differentiation in acinar cells. 
PLAG1 has been reported to act as a regulator of neuronal gene expression and neuronal 
differentiation in neural progenitor cells in the developing mouse neocortex [26]. These results may 
contradict with the findings of the current study wherein, PLAG1 was found to enhance the 
stemness profiles in the acinar cells, which suggests that PLAG1 promotes the dedifferentiation of 
these cells. These conflicting findings may be attributed to the potential role of PLAG1 in 
facilitating asymmetric stem cell division, progenitor division, and lineage differentiation in the 
acinar cells. This speculation may be supported by previous reports which show that PLAG1 is 
required for zygotic genome activation during early preimplantation embryo development [27]. 
Regulation of zygotic genome activation is thought to be closely involved with pluripotency control 
and lineage differentiation [27].  
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It is thought that the constitutive renewal and aberrant expansion of the stem cell pool 
caused by uncontrolled Wnt signaling are required for the development of cancerous tissues [28]. 
Thus, it is possible that PLAG1 aids in the development of salivary gland tumors by increasing the 
number of cells with stemness features in the progenitor cell pool in normal salivary glands by 
virtue of the uncontrolled Wnt signaling. 
Our results showed that the overexpression of PLAG1 in normal human salivary gland 
cells caused different effects on stemness profiles and differentiation in a cell type-specific manner. 
The cell type- and context-specific functions of PLAG1 have been reported previously [29]. The 
roles of PLAG1 in insulin-like growth factor 2 (IGF2) regulation in Hep3B and JEG-3 cells are 
different [29]. It has been suggested that the binding of PLAG1 to the IGF2 P3 promoter resulting 
in IGF2 expression is cell type-specific; furthermore, the PLAG1 transcription factor acts as a 
transcriptional facilitator that partially overrides the insulation by the H19 imprinting control region 
[29]. Epigenetic control at the H19–IGF2 locus for the maintenance of adult stem cells has been 
demonstrated in hematopoietic cells [30]. Furthermore, DNA methylation is required for the control 
of stem cell differentiation in the digestive system [31]. Thus, these differences in the epigenetic 
status between different stem/progenitor acinar and ductal cells in normal salivary glands may be 
responsible for the cell type-specific reactions of PLAG1 overexpression. The results of the present 
study probably account for the histological diversity of salivary gland tumors caused by differences 
in the origin of tumor cells.  
In a previous study, the proliferation rate of NIH3T3 cell lines overexpressing PLAG1 was 
significantly higher than that of mock-infected cells [6]. Moreover, NIH3T3 cell lines 
overexpressing PLAG1 displayed the typical markers of neoplastic transformation: loss of cell-cell 
Journal of Oral Biosciences 
Y. Goto et al. 
19 
 
contact inhibition; anchorage-independent growth; and ability to induce tumors in nude mice [6]. 
PLAG1 has been reported to inhibit cell migration through miR-218-1 by directly targeting RET 
and PLAG1 [32]. The GO term enrichment analysis in the present study showed that signaling 
pathways, such as MAPK, PI3K/AKT, and Ras, were predominantly involved. The MAPK–Snai2 
pathway was found to be involved in the migration and invasion of cells in salivary adenoid cystic 
carcinoma (ACC) [33]. In addition, almost all ACCs overexpressed c-Kit [34, 35], which is thought 
to be a therapeutic molecular target in ACCs [36-38]. The PI3K/AKT, MAPK, and Ras/Raf 
pathways are known to be the downstream effectors of c-Kit [37]. The Ras/RAF/MEK/MAPK and 
PIK3/AKT/mTOR pathways are highly conserved pathways necessary for growth, proliferation, 
differentiation [39], and tumorigenesis [40, 41]. Moreover, the PI3K and MAPK pathways mediate 
salivary gland branching [42]. It is suggested that PLAG1 induces cell proliferation, migration, and 




Our results demonstrated that PLAG1 enhances the stemness profiles of acinar cells in 
normal human salivary glands in a cell type-specific manner. Moreover, the up-regulated genes in 
cells with PLAG1 overexpression were found to be predominantly involved in the stemness-related 
pathway and the MAPK, PI3K/AKT, and Ras signaling pathways. This cell type-specific function 
of PLAG1 might indicate that the histological diversity of salivary gland tumors is caused by 
differences in the origin of tumor cells. Thus, it might be reasonable to conclude that PLAG1 aids in 
Journal of Oral Biosciences 
Y. Goto et al. 
20 
 
the development of salivary gland tumors by increasing the stemness feature in normal salivary 
gland cells. 
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Figure 1.  
PLAG1 overexpression does not affect the cell morphology of acinar and ductal cells. Acinar 
(NS-SV-AC) and ductal (NS-SV-DC) cells were transfected with PLAG1 and empty vector using 
the lipofection method. (A) Cell morphology of acinar (upper) and ductal (lower) cells at 24 h after 
transfection. Scale bar = 100 m. (B) Immunoblotting of acinar and ductal cells at 24 and 48 h after 
PLAG1 transfection. GAPDH was used as the control. 
 
Figure 2. 
PLAG1 promotes cell proliferation and migration of acinar and ductal cells. (A) Cell proliferation 
assay of acinar and ductal cells transfected with PLAG1. The absorbance of acinar (left) and ductal 
(right) cells at 450 nm were measured at five days after the seeding of the cells transfected with 
PLAG1 or an empty vector. (B, C) Transwell migration assay. PLAG1- or empty vector-transfected 
acinar and ductal cells were seeded onto Matrigel Basement Membrane Matrix-coated transwell 
chambers. After 24 h, the cells that had invaded into the lower sides of the membranes were counted 
under the microscope. All values shown are mean  standard deviation (SD) of septuplicate (A) 
or quadruplicate (C) measurements. **P < 0.01. 
 
Figure 3.  
PLAG1 enhances luminal cell-like profiles in acinar cells. (A) Hematoxylin and Eosin (HE) 
staining of salispheres formed from PLAG1-transfected acinar cells. (B) qRT-PCR analysis on 
salispheres formed from PLAG1-transfected acinar cells. All values shown are mean ± standard 
deviation (SD; n = 3-6). *P < 0.05; **P < 0.01; n.d., not detected; n.s., not significant. (C) 
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Immunofluorescence staining of AQP5, CK18, CK14, and SMA (red) in salispheres formed from 
PLAG1-transfected acinar cells. The nuclei were stained with DAPI (blue). The salispheres for all 
results were cultured for 12 or 13 days by salisphere culture. Scale bar = 50 m. 
 
Figure 4. 
PLAG1 slightly reduces the basal cell-like character in ductal cells. (A) HE staining of salisphere 
formed from PLAG1-transfected ductal cells. (B) qRT-PCR analysis of salispheres formed by 
PLAG1-transfected ductal cells. All values shown are mean ± standard deviation (SD; n = 4-6). *P 
< 0.05; n.s., not significant. (C) Immunofluorescence staining of AQP5, CK18, CK14, and SMA 
(red) in salispheres formed by PLAG1-transfected ductal cells. The nuclei were stained with DAPI 
(blue). The salispheres for all results were cultured for 13 days by salisphere culture. Scale bar = 50 
m. 
 
Figure 5.  
PLAG1 enhanced the stemness profiles in acinar cells. (A) qRT-PCR analysis of stem cell markers. 
All values shown are mean ± standard deviation (SD; n = 3-6). *P < 0.05; **P < 0.01; ***P < 
0.001; n.s., not significant. (B) Immunofluorescence staining of POU5F1, NANOG, LGR5, and 
THY1 (red) in salisphere formed by PLAG1-transfected acinar cells. The nuclei were stained with 
DAPI (blue). The salispheres for all results were cultured for 12 or 13 days by salisphere culture. 
Scale bar = 50 m. 
 
Figure 6. 
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PLAG1 increases the expression of THY1 in ductal cells. (A) qRT-PCR analysis of stem cell 
markers. All values shown are mean  standard deviation (SD; n = 4-6). *P < 0.05; n.s., not 
significant. (B) Immunofluorescence staining of POU5F1, NANOG, LGR5, and THY1 (red) in 
salispheres formed by PLAG1-transfected ductal cells. The nuclei were stained with DAPI (blue). 








Pathway ID Description Gene name P-value
hsa04015 Rap1 signaling pathway
FGF19, PRKCZ, ITGAL, FGF8, FLT1, FGFR3, PDGFB,
PDGFA, ADORA2A, ADCY5, FGF17, GRIN1, PIK3CD,
FGF11, FGF21, FGF12, RASSF5, LPAR5, ID1, RASGRP2,
CALML6, RAPGEF3, NGFR, PLCB2, FGF3, FGF4
1.91E-07
hsa05200 Pathways in cancer
FGF19, WNT5A, FGF8, FGFR3, APC2, PDGFB, PDGFA,
WNT3A, ADCY5, FGF17, GNG13, FGF11, FGF12, MMP1,
SHH, GNG8, WNT1, RASGRP2, HHIP, AXIN2, PLCB2,
FGF3, FGF4, CEBPA, RET, PIK3CD, BIRC7, FGF21,
CBLC, RASSF5, WNT7B, LPAR5, WNT11, WNT7A
7.09E-06
hsa04014 Ras signaling pathway
FGF19, FGF8, FLT1, FGFR3, PDGFB, PDGFA, FGF17,
GRIN1, PIK3CD, GNG13, FGF11, FGF21, FGF12, PAK6,
GNG8, RASSF5, KSR2, RASGRP2, CALML6, NGFR,
FGF3, FGF4
8.77E-05
hsa05031 Amphetamine addiction ARC, GRIN2C, PPP1R1B, ADCY5, GRIN2D, GRIN1, TH,CALML6, CAMK2B, FOSB, CAMK2A 1.39E-04
hsa05217 Basal cell carcinoma WNT5A, WNT1, WNT7B, APC2, WNT3A, WNT11,HHIP, AXIN2, WNT7A, SHH 1.41E-04
hsa05218 Melanoma FGF19, FGF8, PDGFB, PDGFA, FGF17, PIK3CD, FGF11,FGF12, FGF21, FGF3, FGF4 2.58E-04
hsa04151 PI3K-Akt signaling pathway
FGF19, FGF8, FGFR3, PDGFB, PDGFA, STK11, FGF17,
GNG13, FGF11, COL2A1, FGF12, GNG8, COMP, NOS3,
PPP2R2C, FGF3, FGF4, IL2RB, FLT1, PIK3CD, NR4A1,
FGF21, CD19, LPAR5, COL1A1, JAK3, NGFR
4.07E-04
hsa04010 MAPK signaling pathway
FGF19, FGF8, NTF4, FGFR3, PDGFB, PDGFA, FGF17,
CACNG7, FGF11, CACNG4, NR4A1, FGF21, FGF12,
DUSP2, RASGRP2, CACNA1G, MAPK8IP2, MAPK8IP1,
DUSP9, CD14, FGF3, FGF4
4.21E-04
hsa04550 Signaling pathways regulating pluripotency of stem cells
WNT5A, FGFR3, APC2, WNT3A, PIK3CD, INHBB,
WNT1, WNT7B, ID1, ID4, WNT11, JAK3, AXIN2,
DUSP9, WNT7A
6.46E-04
hsa04514 Cell adhesion molecules
ITGAL, CADM3, CLDN9, NRXN2, CD8A, CLDN4,
NFASC, LRRC4B, NTNG2, L1CAM, PDCD1LG2,
PDCD1, CDH15, CD34, NLGN4X
7.45E-04
Table 1 Short list of the GO term enrichment analysis with annotation category of Kyoto Encyclopedia of Genes and Genomes pathways
among up-regulated genes in acinar cells with PLAG1 overexpression
Pathway ID Description Gene name P-value
hsa04151 PI3K-Akt signaling pathway
FGF19, FGF8, FLT1, FGF17, EFNA2, COL3A1, PIK3CD, GNG13,
COL2A1, FGF21, FGF12, ITGB3, GNG8, CD19, CREB3L1, PDGFRB,
NOS3, COL1A1, JAK3, PPP2R2C, FGF3, FGF4
2.35E-06
hsa04015 Rap1 signaling pathway
FGF19, ITGAL, FGF8, FLT1, ADORA2A, FGF17, EFNA2, ADCY5,
GRIN1, PIK3CD, FGF12, ITGB3, FGF21, PDGFRB, CALML6, FGF3,
FGF4
2.45E-06
hsa04916 Melanogenesis WNT5A, WNT10A, WNT1, WNT5B, ADCY5, WNT3A, CREB3L1,CALML6, WNT11, POMC, WNT7A, CAMK2A 3.05E-06
hsa05031 Amphetamine addiction ARC, GRIN2C, PPP1R1B, ADCY5, GRIN1, TH, CREB3L1, CALML6,CAMK2A 3.54E-05
hsa05200 Pathways in cancer
WNT5A, FGF19, WNT10A, RET, FGF8, WNT5B, FGF17, WNT3A,
ADCY5, PIK3CD, BIRC7, GNG13, FGF21, FGF12, GNG8, WNT1,
PDGFRB, WNT11, WNT7A, FGF3, FGF4
5.83E-05
hsa05218 Melanoma FGF19, FGF8, FGF17, PIK3CD, PDGFRB, FGF12, FGF21, FGF3, FGF4 6.04E-05
hsa04014 Ras signaling pathway FGF19, FGF8, FLT1, FGF17, EFNA2, GRIN1, PIK3CD, GNG13, FGF12,FGF21, GNG8, PDGFRB, CALML6, FGF3, FGF4 1.09E-04
hsa04261 Adrenergic signaling in cardiomyocytes TNNT2, MYL3, ADCY5, ATP1A3, CACNG4, CREB3L1, SCN4B,CALML6, TNNI3, CAMK2A, PPP2R2C 3.15E-04
hsa05030 Cocaine addiction GRM2, GRIN2C, PPP1R1B, ADCY5, GRIN1, TH, CREB3L1 3.30E-04
hsa04024 cAMP signaling pathway HCN2, ADORA2A, ADCY5, PIK3CD, GRIN1, ATP1A3, TNNI3,PPP1R1B, GRIN2C, PDE4A, CREB3L1, CALML6, CAMK2A 4.20E-04
Table 2 Short list of the GO term enrichment analysis with annotation category of Kyoto Encyclopedia of Genes and Genomes pathways
among up-regulated genes in ductal cells with PLAG1 overexpression
